Deciphera Pharmaceuticals LLC (DCPH)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$2.21B
EV to revenue ratio (TTM)
11.24
EV to ebitda
-4.53
Financial Performance
Revenue (TTM)
$0.17B
Gross profit (TTM)
-$0.06B
EBITDA
-$0.20B
Profitability
Operating margin (TTM)
-108.50%
Profit margin
-108.90%
Return on assets (TTM)
-26.60%
Return on equity (TTM)
-50.40%
Per Share Metrics
Revenue per share (TTM)
$2.03
EPS
-$2.21
Diluted EPS (TTM)
-$2.21
Book value
$3.85
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
12.65
Price to book ratio (TTM)
7
Growth
Quarterly earnings growth (YoY)
34.50%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
0.18